Novo Holdings’ investment alongside Biocomposites’ existing shareholder, TA Associates, will help the company scale its pipeline.

Biocomposites is headquartered in Keele, UK TA has been Biocomposites’ majority shareholder since 2017 Novo Holdings and TA Associates have agreed to make an investment into Biocomposites.

Novo Holdings and TA Associates ("TA"), announced today that the parties have entered into an agreement for Novo Holdings to make an investment in Biocomposites ("the Company"), an international ...

Since partnering with TA in 2017, Biocomposites has achieved significant growth – including a threefold increase in revenues, successful geographic expansion, and continued product diversification.

Biocomposites’ CEO Michael Harris commented: “TA has been a fantastic long-term partner to us, and we are excited for the future alongside them and Novo Holdings.” ...

HELLERUP, Denmark, LONDON and KEELE, England, March 3, 2025 /PRNewswire/ -- Novo Holdings and TA Associates ("TA"), announced today that the parties have entered into an agreement for Novo ...

As part of the transaction TA, Biocomposites' majority shareholder since 2017, will reinvest in the Company alongside new investor Novo Holdings and Biocomposites' management.

Novo Holdings And TA Associates Partner With Biocomposites To Drive Next Chapter Of Its Growth. Date. 2025-03-03 03:45:54 ...